Evidence map›Paper›PMID 26264812›Full record

Trial reportDiabetes, obesity & metabolism2015

Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.

S Franc, A Daoudi, A Pochat, M-H Petit, C Randazzo, C Petit, M Duclos, A Penfornis, E Pussard, D Not and 4 more

Open access · hybridAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Diabetes, obesity & metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Association of HbA1c with VOMetabolites · 2022
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

S FrancCentre for Study and Research for Improvement of the Treatment of Diabetes (CERITD), Evry, France.
A DaoudiCentre for Study and Research for Improvement of the Treatment of Diabetes (CERITD), Evry, France.
A PochatCentre for Study and Research for Improvement of the Treatment of Diabetes (CERITD), Evry, France.
M-H PetitCentre for Study and Research for Improvement of the Treatment of Diabetes (CERITD), Evry, France.
C RandazzoCentre for Study and Research for Improvement of the Treatment of Diabetes (CERITD), Evry, France.
C PetitCentre for Study and Research for Improvement of the Treatment of Diabetes (CERITD), Evry, France.
M DuclosDepartment of Sport Medicine and Functional Exploration, Clermont-Ferrand University Hospital, UMR1019 CRNH, Clermont-Ferrand, France.
A PenfornisDepartment of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, France.
E PussardMolecular Genetics, Pharmacogenetics and Hormonology Laboratory, Bicêtre University Hospital, Kremlin-Bicêtre, France.
D NotRCTs, Lyon, France.
E Heyman'Physical Activity, Muscle, Health' Research Team, URePSSS, University of Lille, Lille, France.
F KoukouiDepartment of Cardiology, Sud-Francilien Hospital, Corbeil-Essonnes, France.
C SimonDepartment of Endocrinology, Diabetes and Metabolic Diseases, Lyon Sud University Hospital, Pierre-Bénite, France.
G CharpentierCentre for Study and Research for Improvement of the Treatment of Diabetes (CERITD), Evry, France.
Centre d'Etudes et de Recherches pour l'Intensification du Traitement du Diabète · FRCentre Hospitalier Sud Francilien · FRBicêtre Hospital · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRHôpital Lyon Sud · FRL’Agence Nationale pour l’amélioration des Conditions de Travail · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo validate strategies to prevent exercise-induced hypoglycaemia via insulin-dose adjustment in adult patients with type 1 diabetes (T1D) on pump therapy.

methodsA total of 20 patients randomly performed four 30-min late post-lunch (3 h after lunch) exercise sessions and a rest session: two moderate sessions [50% maximum oxygen consumption (VO2 max)] with 50 or 80% basal rate (BR) reduction during exercise + 2 h and two intense sessions (75% VO2 max) with 80% BR reduction or with their pump stopped. Two additional early post-lunch sessions (90 min after lunch) were analysed to compare hypoglycaemia incidence for BR reduction versus bolus reduction.

resultsIn all, 100 late post-lunch sessions were analysed. Regardless of exercise type and BR reduction, no more hypoglycaemic events occurred in the period until the next morning than occurred after the rest sessions. In the afternoon, no more hypoglycaemic events occurred with 80% BR reduction/moderate exercise or with pump discontinuation/intense exercise than for the rest session, whereas more hypoglycaemic events occurred with 50% BR reduction/moderate exercise and 80% BR reduction/intense exercise. After early post-lunch exercise (n = 37), a trend towards fewer hypoglycaemic episodes was observed with bolus reduction versus BR reduction (p = 0.07). Mean blood glucose fell by ∼3.3 mmol/l after 30 min of exercise, irrespective of dose reduction, remaining stable until the next morning with no rebound hyperglycaemia.

conclusionIn adults with T1D, to limit the hypoglycaemic risk associated with 30 min of exercise 3 h after lunch, without carbohydrate supplements, the best options seem to be to reduce BR by 80% or to stop the pump for moderate or intense exercise, or for moderate exercise 90 min after lunch, to reduce the prandial bolus rather than the BR.

Indexed as

ExerciseInsulin Infusion SystemsAdultAlgorithmsBlood GlucoseCross-Over StudiesDiabetes Mellitus, Type 1FemaleHumansHypoglycemiaHypoglycemic AgentsIncidenceInsulinLunchMaleMiddle AgedBlood GlucoseHypoglycemic AgentsInsulincontinuous subcutaneous insulin infusionexerciseglycaemic controlinsulin pump therapytype 1 diabetes

Identifiers

PMID26264812
PMCPMC5057323
OpenAlexW1923792191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.